Edwards Lifesciences Corporation
$94.81
+3.03 · +3.30% today
Market open · updated 12:44:26 PM ET
- High
- $92.56 4:30 AM
- Low
- $92.54 5:30 AM
Against the S&P 500 Price change through Oct 28, 2026
EW+7.66%
S&P 500+13.26%
EW+11.67%
S&P 500+12.41%
EW—
S&P 500+88.06%
EW—
S&P 500+68.51%
Key numbers
- Previous close
- $91.78
- Open
- $92.63
- Day's range
- $92.00 – $95.20
- 52-week range
- $74.66 – $96.29
- Volume
- 1.6 million
- Average volume
- 3.9 million
- Market value
- $54.6 billion
- Price to earnings
- 52.7last 12 months
- Earnings per share
- $1.74last 12 months
- Beta
- 0.86moves about as much as the market
- Dividend
- None
- 50-day average
- $88.06
- 200-day average
- $85.33
Wednesday, Nov 4, 2026, after the close.
Analyst price targets and the full financials are in the terminal.
Who Edwards Lifesciences buys from and competes with From our value chain
Edwards Lifesciences in the news
No desk stories on EW yet. When we write about it, the story leads this list.
- HeadlineIs This the Right Time to Hold EW Stock in Your Portfolio?Zacks Investment Research · October 22, 2026 at 9:51 AM ET
- CongressRo Khanna bought $1,001 - $15,000 of EWHouse filing · disclosed Jun 11, 2026
- CongressJosh Gottheimer sold $1,001 - $15,000 of EWHouse filing · disclosed Dec 30, 2025
- CongressRo Khanna sold $1,001 - $15,000 of EWHouse filing · disclosed Nov 14, 2025
- CongressBruce Westerman sold $1,001 - $15,000 of EWHouse filing · disclosed May 13, 2025
- CongressJefferson Shreve bought $15,001 - $50,000 of EWHouse filing · disclosed May 9, 2025
- CongressRob Bresnahan bought $1,001 - $15,000 of EWHouse filing · disclosed May 8, 2025
- CongressBruce Westerman bought $1,001 - $15,000 of EWHouse filing · disclosed Apr 17, 2025
Earnings
Next report: Wednesday, Nov 4, 2026, after the close.
Congress trades in EW
4 purchases and 3 sales in the latest 7 filings.
| Member | Trade | Amount | Traded | Disclosed |
|---|---|---|---|---|
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | May 1, 2026 | Jun 11, 2026 |
| Josh GottheimerHouse · D-New Jersey | Sale | $1,001 - $15,000 | Nov 19, 2025 | Dec 30, 2025 |
| Ro KhannaHouse · D-California | Sale | $1,001 - $15,000 | Oct 7, 2025 | Nov 14, 2025 |
| Bruce WestermanHouse · R-Arkansas | Sale | $1,001 - $15,000 | Apr 21, 2025 | May 13, 2025 |
| Jefferson ShreveHouse · R-Indiana | Purchase | $15,001 - $50,000 | Apr 7, 2025 | May 9, 2025 |
| Rob BresnahanHouse | Purchase | $1,001 - $15,000 | Apr 8, 2025 | May 8, 2025 |
| Bruce WestermanHouse · R-Arkansas | Purchase | $1,001 - $15,000 | Mar 3, 2025 | Apr 17, 2025 |
Source: Periodic transaction reports filed with the House and the Senate · Members disclose ranges, not exact amounts, and may file weeks after the trade.
About Edwards Lifesciences
Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 16,000
- Headquarters
- Irvine, California
- Website
- edwards.com
- Listed
- Mar 27, 2000
More medical - devices stocks
The price refreshes every 15 seconds while the market is open and carries the time it was read. Company figures are updated each evening. Built from WiseView and market data and public filings. For information only, not investment advice.